Browsing: Pharma

To expand its reach in the ADHD market, Collegium Pharmaceutical has entered into an agreement…

AlphaSigma’s buzzer-beater bet on GSK’s prospects for rare liver diseases has paid off. Last week,…

Following a major investment in China, AstraZeneca on Thursday announced plans to build a commercial…

Pfizer is eyeing early use of its PARP inhibitor Tarzenna after positive results in a…

Many of President Donald Trump’s campaign promises to lower drug prices in the United States…

Shares of Indianapolis drugmaker Eli Lilly have fallen more than 7% since investment bank HSBC…

With the long-awaited new approval of a daily pill, Johnson & Johnson and Protagonist Therapeutics…

As interest in the cancer-fighting potential of radiopharmaceuticals continues to grow, companies have made a…

More than 20 years after FDA approval of Flovent, GSK still dominates the U.S. asthma…

Building on years of significant investment from big pharmaceutical companies, Indiana is moving forward with…